Dermatology Times, November 2022 (Vol. 43. No. 11)

There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.

Newly approved laser treatments can be an effective option for the treatment of this common skin disorder.

Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.

In this month's Finance & Practice Management article, Carole C. Foos, CPA, and David B. Mandell, JD, MBA, give an overview of potential upcoming tax law changes.

Recent, continued research in genetic profiling has made personalized medicine more of a reality and brought the concept a step closer to potential regular use in general dermatology practice.

More and more, clinicians are using oral minoxidil to treat patients with hair loss. Is it working?

Precision medicine may help improve the diagnosis and management of this aggressive skin cancer.

Experts discuss game-changing drugs and what’s in the pipeline.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, reviews how to prevent hand dermatitis.

Hidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.

Tips on growing your practice.

In this month's Legal Eagle column, David J. Goldberg, MD, JD, reviews a lawsuit case regarding employee termination.

Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.

Epidermolysis bullosa is a broad term used to identify a group of genetic disorders that result in skin blistering and fragility.

At the 2022 Fall Clinical Dermatology Conference, a dermatologist shares results of using cemiplimab-rwlc (Libtayo) for basal and squamous cell carcinoma.

At the 2022 Fall Clinical Dermatology Conference, Bruce E. Strober, MD, PhD, reviewed the best treatment options for patients with psoriasis and psoriatic arthritis.

At the 2022 Fall Clinical Dermatology Conference, one clinician discusses history, definitions, and diagnosis for this common skin affliction.

At the 2022 Fall Clinical Dermatology Conference, 3 expert clinicians share their strategies for diagnosing and managing alopecia areata.

At the 2022 Fall Clinical Dermatology Conference,a presenter looks at the best treatments for hair loss and nail fungus.

The 40-gene expression profile (40-GEP) test can focus treatment options and optimize patient outcomes, according to a poster presentation at the 2022 Fall Clinical Dermatology Conference.

At the 2022 Fall Clinical Dermatology Conference, Joslyn R. Sciacca Kirby, MD, MS, MEd, and Raj Chovatiya, MD, PhD, discussed how there is a large unmet need for hidradenitis suppurativa treatment and what future treatment could look like.

At the 2022 Fall Clinical Dermatology Conference, Valerie D. Callender, MD, FAAD, presents “What’s Hot in Acne & Rosacea.”

At the 2022 Fall Clinical Dermatology Conference, 2 clinicians discuss the best skin cleanser recommendations for their patients.

Harold J. Brody, MD, provides his best tips and tricks for superficial and medium depth chemical peels in a presentation at the 2022 ASDS Annual Meeting.

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.

Pearl Grimes, MD, FAAD, dives deep into chemical peels, especially for your skin of color patients, at the 2022 ASDS Annual Meeting.

At the Melanoma Update of the Annual ASDS Meeting, Tyler Hollmig, MD, looked at complex clinical scenarios when treating melanoma and the continued challenges dermatologists face.

There are multiple factors predicting itch-specific quality of life in patients with chronic itch, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.

NEXGEL’s dressing demonstrates significant scar improvement as early as 6 weeks after surgery.

New research finds psoriasis drug apremilast could help patients lose weight.